Prostate News Archive
28-Dec-2008
Ferring wins FDA approval for prostate cancer drug (Pharmaceutical Business Review)
Ferring Pharmaceuticals USA has received approval from the FDA for degarelix, a new injectable gonadotropin-releasing hormone receptor antagonist, indicated for patients with advanced prostate cancer. Gay/bisexual black men lag behind others in prostate cancer screening (Gayapolis)
Many doctors recommend that once men reach 50, they should be screened for prostate and colorectal cancer. However, not all men get those tests, and a recent study has found that discrepancies exist among some groups. St. James offers new treatment for prostate cancer (The Montana Standard)
A new procedure to combat prostate cancer is being performed at St. James Healthcare in Butte. Long menu of treatment for prostate enlargement (The Brockville Recorder and Times)
Dear Dr. Donohue: About three years ago, I had a procedure to reduce the size of my prostate. It was Greenlight PVP laser procedure. My [...]
Back to Prostate News Archive